Unaltered Secretion of β-Amyloid Precursor Protein in Gelatinase A (Matrix Metalloproteinase 2)-deficient Mice*
Abstract
The β-amyloid peptide, which forms extracellular cerebral deposits in Alzheimer’s disease, is derived from a large membrane-spanning glycoprotein referred to as the β-amyloid precursor protein (APP). The APP is normally cleaved within the β-amyloid region by a putative proteinase (α-secretase) to generate large soluble amino-terminal derivatives of APP, and this event prevents the β-amyloid peptide formation. It has been suggested that the gelatinase A (matrix metalloproteinase 2, a 72-kDa type IV collagenase) may act either as α-secretase or as β-secretase. Mice devoid of gelatinase A generated by gene targeting develop normally, except for a subtle delay in their growth, thus providing a useful system to examine the role of gelatinase A in the cleavage and secretion of APP in vivo. We show here that APP is cleaved within the β-amyloid region and secreted into the extracellular milieu of brain and cultured fibroblasts without gelatinase A activity. The data suggest that gelatinase A does not play an essential role in the generation and release of soluble derivatives of APP at physiological conditions.
Footnotes
-
↵* This work was partly supported by a Grant-in-Aid for Scientific Research B from the Ministry of Education, Science, Sports and Culture and a grant from the Shionogi Institute for Medical Science (to S. I.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵§ Present address: Shionogi Inst. for Medical Science, Shionogi & Co., Ltd. 12-4, 5, Sagisu, Fukushima-ku, Osaka 553, Japan.
-
↵‖ To whom correspondence should be addressed. Tel.: 81-75-751-3990; Fax: 81-75-761-5626; E-mail:sitohara{at}virus.kyoto-u.ac.jp.
- Received April 30, 1997.
- Revision received June 16, 1997.











